IMGM Laboratories GmbH

What IMGM Laboratories GmbH does

IMGM Laboratories GmbH, founded in 2001 and headquartered in Martinsried, Germany, is a specialty genomics services provider focused on clinical trials and precision medicine. The company delivers DNA and RNA sequencing, biomarker discovery and validation, pharmacogenetics, high-resolution NGS-based HLA typing, PBMC isolation, and companion diagnostic (CDx) development, alongside GLP-compliant long-term sample archiving and biobanking at its Martinsried facility. Its customer base is composed of pharmaceutical companies running genomic-driven clinical studies, with services integrated into sponsor protocols and regulatory submissions under IVDR, CE-IVD, GCP, GCLP, and ISO 9001/15189/13485 frameworks.

IMGM now operates as part of Medicover Integrated Clinical Services (MICS), a specialized business unit of Medicover AB, following an acquisition that expanded MICS's central laboratory, precision medicine, and clinical trial support capabilities across Europe. Through MICS, IMGM's genomic offerings are delivered alongside a broader portfolio including central lab services covering over 12,000 validated assays, site management organization access across European medical centers, and strategic collaborations (e.g., with Frontage Laboratories) for global genomic testing reach. The combined platform targets therapeutic areas such as oncology, immunology, CNS, vaccines, rare and orphan diseases, and cell and gene therapy. Pricing is not publicly disclosed and is handled through direct sales engagement, consistent with enterprise B2B clinical trial services contracting.

Name

IMGM Laboratories GmbH

Legal name

IMGM Laboratories GmbH

Website

https://imgm.com

Company type

Private

Founded year

2001

Operating status

Acquired

Headcount range

11–50 employees

Short description

IMGM Laboratories GmbH is a Martinsried, Germany-based specialty genomics services provider for clinical trials and precision medicine, offering sequencing, biomarker discovery, companion diagnostics, and biobanking to pharmaceutical sponsors, now operating within Medicover Integrated Clinical Services (MICS).

Ownership category

akta.pro rank

Headquarters

HQ city

Martinsried

HQ country

Germany

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Core offering

IMGM Laboratories GmbH is a Martinsried-based genomic services laboratory that provides molecular and genomic testing for clinical trials, including biomarker discovery and validation, pharmacogenetic testing, companion diagnostic (CDx) development with IVDR compliance, high-resolution HLA typing, PBMC isolation, and GLP-compliant biobanking. Following its acquisition by Medicover Integrated Clinical Services (MICS), its offerings are delivered as part of an integrated central laboratory, precision medicine, and site management organization platform serving pharmaceutical and biotech sponsors across Europe.

Product overview

Medicover Integrated Clinical Services (MICS), which acquired IMGM Laboratories GmbH, operates as an integrated clinical development platform offering central laboratory services, precision medicine, and site management organization solutions. The product portfolio includes Precision Medicine Services (genomic testing, biomarker development, companion diagnostics), Central Lab Services (over 12,000 validated assays), and Site Management Organisation across European medical centers. Key sub-services include HLA typing, pharmacogenetics, PBMC isolation, and GLP-compliant biobanking. The integrated model provides a pan-European laboratory infrastructure with single-point project management coordination.

Differentiator

Problem solved

Functional benefit

Products and services

• Precision Medicine Services Personalized molecular and genomic testing services for clinical trials, including biomarker discovery, pharmacogenetics, and companion diagnostic development, intended for pharmaceutical and biotech sponsors.
• Companion Diagnostics (CDx) Solutions Integrated support for companion diagnostic programs, spanning early feasibility and assay design through regulatory submission and commercialization, including IVDR compliance, for diagnostic developers and pharma sponsors.
• Central Lab Services Comprehensive central laboratory services coordinating every aspect of clinical trial laboratory operations with over 12,000 validated assays for clinical trial sponsors.
• Site Management Organisation Site management organization services providing global access to patients through medical centers, supporting successful and patient-centric clinical trials for pharmaceutical and biotech sponsors.
• Genomic Testing Services NGS-based genomic profiling services, including exome sequencing, targeted gene panels, and tumor profiling, delivered through the Medicover laboratory network for clinical trials and precision medicine programs.
• Biomarker Development Tailored analytical solutions for biomarker-driven studies, including assay selection, coordinated testing, and quality-controlled reporting for patient stratification and therapy monitoring, for clinical trial sponsors.
• Pharmacogenetics Services Coordinated validated gene panels including CYP450 and key metabolism markers supporting personalized medicine strategies for clinical trial sponsors.
• HLA Typing and Immunogenetics High-resolution NGS-based HLA genotyping across major loci (HLA-A, -B, -C, -DRB1, -DQB1, -DPB1) for transplantation, immunotherapy, and vaccine studies.
• PBMC Isolation Capabilities Peripheral blood mononuclear cell (PBMC) isolation services for clinical trial biomarker and immunology studies.
• GLP-Compliant Archive and Biobanking Long-term document and sample archiving via GLP-compliant facility in Martinsried with electronic traceability, SOP-governed storage, and secure access for clinical trial samples and records.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Medicover Integrated Clinical Services (MICS)coreStrategic or Co-development PartnerIMGM Laboratories GmbH has been acquired by Medicover Integrated Clinical Services (MICS). This integration expands MICS's capabilities across central laboratory services, precision medicine, and clinical trial support. IMGM serves as a trusted partner for genomic services within the MICS network, contributing specialized expertise in genomic testing and precision medicine solutions.

Recent moves2 records

Expansion highlights5 records

Direct peers

• ICON Central Laboratories: ICON Central Labs (formerly ACM Global) provides global central lab, biomarker, and genomic testing services to clinical trials. Highly comparable to IMGM's central lab and precision medicine stack, with similar sponsor customers and trial support model.
• MLM Medical Labs: MLM Medical Labs is a German/Düsseldorf-based central and specialty laboratory serving clinical trials across Europe with genomic and bioanalytical capabilities. Highly comparable mid-sized European competitor to IMGM.
• Cerba HealthCare: Cerba HealthCare operates a network of specialty clinical and central laboratories in Europe offering genomic and biomarker testing for clinical trials and routine diagnostics. Comparable as a European specialty lab with clinical trial services.
• Frontage Laboratories: Frontage Laboratories provides bioanalytical, genomic, and biomarker services for clinical trials globally and is IMGM's named strategic collaboration partner under MICS. Comparable services, similar sponsor base, and active overlap in genomic testing for trials.
• BARC Global Central Laboratory: BARC is a Belgium-based global central lab serving clinical trials with genomic and bioanalytical services, headquartered in Europe. Directly comparable to IMGM in geographic focus, central lab model, and precision medicine service scope.
• Q² Solutions: Q² Solutions (IQVIA/Quest JV) provides central lab, genomic, and bioanalytical services for clinical trials. Comparable in central lab + precision medicine focus and in competing for the same pharma/biotech sponsor trials.
• Eurofins Central Laboratory: Eurofins Central Laboratory operates a global central lab network supporting clinical trials with genomic, bioanalytical, and specialty biomarker services. It is the closest direct competitor to IMGM/MICS in terms of central lab + precision medicine offering for pharma trials.

Regional players

• Unilabs Clinical Trials: Unilabs is a European clinical/diagnostic laboratory group offering central lab and specialty testing services to clinical trials. Comparable in European footprint and clinical lab services, though broader diagnostic focus than IMGM.

Broad incumbents

• Medpace Reference Laboratories: Medpace operates an integrated CRO with an in-house central laboratory providing genomic and biomarker testing for its clinical trials. Overlaps with IMGM but is bundled inside a larger full-service CRO rather than a standalone lab.
• Labcorp Central Laboratory Services: Labcorp (incl. legacy Covance) operates one of the largest global central lab networks offering genomic, biomarker, and bioanalytical services for clinical trials. Overlaps directly with IMGM but at much greater scale and geographic breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/imgm-laboratories-ltd

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IMGM Laboratories GmbH